New patent expiration for Astrazeneca drug FASLODEX
Annual Drug Patent Expirations for FASLODEX Faslodex is a drug marketed by Astrazeneca and is included in one NDA. It […]
New patent expiration for Astrazeneca drug FASLODEX Read Post »
Annual Drug Patent Expirations for FASLODEX Faslodex is a drug marketed by Astrazeneca and is included in one NDA. It […]
New patent expiration for Astrazeneca drug FASLODEX Read Post »
Annual Drug Patent Expirations for RESCULA Rescula is a drug marketed by Sucampo Pharma Llc and is included in one
New patent expiration for Sucampo Pharma drug RESCULA Read Post »
Annual Drug Patent Expirations for XENLETA Xenleta is a drug marketed by Nabriva and is included in two NDAs. There
Annual Drug Patent Expirations for BRILINTA Brilinta is a drug marketed by Astrazeneca and is included in one NDA. It
New patent expiration for Astrazeneca drug BRILINTA Read Post »
Annual Drug Patent Expirations for MYCAMINE Mycamine is a drug marketed by Astellas and is included in one NDA. It
New patent expiration for Astellas drug MYCAMINE Read Post »
FASLODEX (fulvestrant) Astrazeneca Patent: 7,456,160 Expiration: Jul 9, 2021 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of July 4, 2021 Read Post »
Annual Drug Patent Expirations for NATROBA Natroba is a drug marketed by Parapro Llc and is included in one NDA.
New patent expiration for Parapro Llc drug NATROBA Read Post »
Annual Drug Patent Expirations for LIDOSITE+TOPICAL+SYSTEM+KIT Lidosite Topical System Kit is a drug marketed by Vyteris and is included in
New patent expiration for Vyteris drug LIDOSITE TOPICAL SYSTEM KIT Read Post »
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two
New patent expiration for Paratek Pharms drug NUZYRA Read Post »
Get fresh news and insights, drug patent expirations & more…